We are live on ! Find out more
PRC

Pearl River Capital Portfolio holdings

AUM $630M
1-Year Est. Return 17.08%
This Fund
S&P 500
This Quarter Est. Return
+11.57%
1 Year Est. Return
+17.08%
3 Year Est. Return
+20.29%
5 Year Est. Return
+57.93%
10 Year Est. Return
–
AUM
$590M
AUM Growth
+$51.8M
Cap. Flow
+$16.7M
Cap. Flow %
2.83%
Top 10 Hldgs %
10.58%
Holding
599
New
158
Increased
165
Reduced
167
Closed
108

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$8.41M
2
XOM icon
ExxonMobil
XOM
+$8.17M
3
AAPL icon
Apple
AAPL
+$4.15M
4
TXN icon
Texas Instruments
TXN
+$4.09M
5
ADBE icon
Adobe
ADBE
+$3.93M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$7M
2
DIS icon
Walt Disney
DIS
+$6.98M
3
MSFT icon
Microsoft
MSFT
+$6.69M
4
RTX icon
RTX Corp
RTX
+$5.96M
5
MRK icon
Merck
MRK
+$5.73M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.61%
2 Technology 15.28%
3 Healthcare 14.63%
4 Industrials 12.62%
5 Financials 12.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RJF icon
376
Raymond James Financial
RJF
$34.7B
$373K 0.06%
3,490
+355
+11% +$39.8K
VAC icon
377
Marriott Vacations Worldwide
VAC
$3.5B
$371K 0.06%
+2,754
New +$384K
U icon
378
Unity
U
$15.4B
$367K 0.06%
12,821
-9,688
-43% -$303K
DOO
379
Bombardier Recreational Products
DOO
$4.85B
$366K 0.06%
+4,800
New +$334K
ENOV icon
380
Enovis
ENOV
$1.73B
$363K 0.06%
6,791
-1,850
-21% -$95.5K
AME icon
381
Ametek
AME
$58.7B
$358K 0.06%
2,565
-3,619
-59% -$480K
NARI
382
DELISTED
Inari Medical, Inc. Common Stock
NARI
$357K 0.06%
5,620
+121
+2% +$8.77K
EXEL icon
383
Exelixis
EXEL
$14.2B
$352K 0.06%
21,942
-7,358
-25% -$120K
SBNY
384
DELISTED
Signature Bank
SBNY
$350K 0.06%
3,041
-810
-21% -$111K
TROX icon
385
Tronox
TROX
$943M
$346K 0.06%
25,230
-5,426
-18% -$72.2K
BNL icon
386
Broadstone Net Lease
BNL
$4.06B
$344K 0.06%
21,192
-1,297
-6% -$21.7K
LYFT icon
387
Lyft
LYFT
$6.18B
$343K 0.06%
31,152
-28,885
-48% -$348K
DAL icon
388
Delta Air Lines
DAL
$61.5B
$341K 0.06%
10,373
-4,549
-30% -$151K
HCP
389
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$340K 0.06%
+12,438
New +$352K
FISV
390
Fiserv Inc
FISV
$28.8B
$339K 0.06%
3,354
-1,541
-31% -$153K
WAFD icon
391
WaFd
WAFD
$2.79B
$337K 0.06%
+10,038
New +$351K
SCI icon
392
Service Corp International
SCI
$11.6B
$333K 0.06%
+4,815
New +$321K
NLY icon
393
Annaly Capital Management
NLY
$17B
$332K 0.06%
15,749
-33,401
-68% -$657K
BILL icon
394
BILL Holdings
BILL
$4.82B
$331K 0.06%
+3,037
New +$365K
SHOO icon
395
Steven Madden
SHOO
$3.56B
$327K 0.06%
+10,247
New +$321K
CNXC icon
396
Concentrix
CNXC
$1.56B
$327K 0.06%
2,457
+14
+0.6% +$1.7K
SAIC icon
397
Saic
SAIC
$5.08B
$327K 0.06%
2,945
-706
-19% -$74.4K
EVH icon
398
Evolent Health
EVH
$342M
$326K 0.06%
+11,595
New +$332K
KSS icon
399
Kohl's
KSS
$2.23B
$323K 0.05%
+12,779
New +$362K
NSP icon
400
Insperity
NSP
$1.96B
$323K 0.05%
+2,840
New +$322K
14 15
16
17 18

Similar funds

SCM
Sahana Capital Management Greenwich, Connecticut $645M AUM 23.48% 1-Year Est. Return
IFAM
Institutional & Family Asset Management Fort Collins, Colorado $654M AUM 12.29% 1-Year Est. Return
GIM
Greylin Investment Management Orange, Virginia $598M AUM 18.59% 1-Year Est. Return
MCM
McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return
AT
Arden Trust Wilmington, Delaware $716M AUM 17.63% 1-Year Est. Return
AC
Abbrea Capital Greenbrae, California $755M AUM 24.68% 1-Year Est. Return
PWS
Private Wealth Strategies New Albany, Ohio $498M AUM 17.23% 1-Year Est. Return
RVPG
Relative Value Partners Group $772M AUM 15.6% 1-Year Est. Return

Pearl River Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Pearl River Capital held 599 positions worth $590M, up 9.6% from $538M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Pearl River Capital's Q4 2022 filing shows 158 new, 165 increased, 167 reduced and 108 closed positions. Its largest new stake was Bristol-Myers Squibb: 111,556 shares worth $8.03M. The largest sale was Pfizer, an estimated $7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

  • Pearl River Capital's largest Q4 2022 buy was Bristol-Myers Squibb: 111,556 shares worth $8.03M.
  • Pearl River Capital added most to Honeywell in Q4 2022, an estimated $3.3M increase.
  • Pearl River Capital's biggest Q4 2022 reduction was Qualcomm, cutting an estimated $5.05M.
  • Pearl River Capital fully exited Pfizer in Q4 2022, selling an estimated $7M.
  • Pearl River Capital's ten largest holdings make up 11% of its $590M portfolio in Q4 2022.
  • Pearl River Capital opened 158 new positions and closed 108 in Q4 2022.
  • Pearl River Capital's portfolio value rose 9.6% quarter-over-quarter to $590M.

Based on Pearl River Capital's 13F filing for Q4 2022, filed 13 Feb 2023.